Ontology highlight
ABSTRACT: Purpose
To evaluate the role of PPARγ in regulating meibocyte differentiation and lipid synthesis in a human meibomian gland epithelial cell line (hMGEC).Methods
HMGEC were exposed to the PPARγ agonist, Rosiglitazone, from 10-50 μM. Cultures were also exposed to specific PPARγ antagonist, T0070907, to block PPARγ receptor signaling. Cells were then stained with Ki-67 and LipidTox to determine the effects on cell cycling and lipid synthesis, respectively. Expression of meibocyte differentiation related proteins, ADFP, PPARγ, ELOVL4, and FABP4, were evaluated by quantitative PCR and western blotting. A human corneal epithelial cell line (hTCEpi) was used as a control.Result
Rosiglitazone significantly decreased Ki-67 staining within 2 days in a dose-dependent manner (
SUBMITTER: Kim SW
PROVIDER: S-EPMC6434942 | biostudies-literature | 2018 Oct
REPOSITORIES: biostudies-literature